-
Pfizer Inc. et al v. Mylan Inc. et al DC CAFC
- 1:10-cv-00528
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 06/16/2010
- Closed: 10/23/2014
- Latest Docket Entry: 02/19/2016
- PACER
- Docket updated daily
7
Plaintiffs
2
Defendants
1
Accused
Product
3
Patents-in-Suit
1,957
Days in
Litigation
-
Pfizer Inc. et al v. Mylan Inc. et al DC CAFC
- 1:10-cv-00528
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 06/16/2010
- Closed: 10/23/2014
- Latest Docket Entry: 02/19/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A compound that is the L-malate salt of 5-(5-fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide.
|
Valid (103)
Entry 170 Entry 165 |
| 2 |
A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier or excipient.
|
Valid (103)
Entry 170 Entry 165 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 5 |
The compound or salt of claim 1, wherein the compound is selected from the group consisting of: <CWU><CHEM-US ID="CHEM-US-00209"><CHEMCDX ID="CHEMCDX-00209" ALT="chemistry chemdraw file" FILE="US06573293-20030603-C00209.CDX"/><CHEMMOL
view more
|
Valid (103)
Entry 170 Entry 165 |
| 21 |
A pharmaceutical composition, comprising a compound or salt of claim 5 and, a pharmaceutically acceptable carrier or excipient.
|
Valid (103)
Entry 170 Entry 165 |
-
Infringement
Mylan Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Sunitinib Malate Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg | US 6,573,293 B2 |
5, 21
|
Infringement
Entry 170
|
| Sunitinib Malate Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg | US 7,125,905 B2 |
1, 2
|
Infringement
Entry 170
|
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Sunitinib Malate Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg | US 6,573,293 B2 |
5, 21
|
Infringement
Entry 170
|
| Sunitinib Malate Capsules 12.5 mg, 25 mg, 37.5 mg, 50 mg | US 7,125,905 B2 |
1, 2
|
Infringement
Entry 170
|
